A new treatment called Coartem Baby was approved in July as the first malaria drug specifically for newborns and infants, a critical leap forward for protecting life at its earliest stage.
A national survey reveals that the stunting rate among Indonesian children is declining, marking positive progress towards reaching the 14% target by 2029, set by the country’s President.